Cover Image

Results of tadalafil treatment in patients following an open nerve-sparing radical prostatectomy

Erkan Hirik, Aliseydi Bozkurt, Mehmet Karabakan, Özkan Onuk, Mustafa Bahadır Can Balcı, Memduh Aydın, Murat Çakan, Barıs Nuhoglu
  • Erkan Hirik
    Erzincan University Mengücek Gazi Education and Research Hospital, Urology Clinic, Turkey | ehirik@gmail.com
  • Aliseydi Bozkurt
    Erzincan University Mengücek Gazi Education and Research Hospital, Urology Clinic, Turkey
  • Mehmet Karabakan
    Erzincan University Mengücek Gazi Education and Research Hospital, Urology Clinic, Turkey
  • Özkan Onuk
    Gaziosmanpasa Taksim Education and Research Hospital, Urology Clinic, Turkey
  • Mustafa Bahadır Can Balcı
    Gaziosmanpasa Taksim Education and Research Hospital, Urology Clinic, Turkey
  • Memduh Aydın
    Gaziosmanpasa Taksim Education and Research Hospital, Urology Clinic, Turkey
  • Murat Çakan
    Erzincan University Mengücek Gazi Education and Research Hospital, Urology Clinic, Turkey
  • Barıs Nuhoglu
    Erzincan University Mengücek Gazi Education and Research Hospital, Urology Clinic, Turkey

Abstract

Purpose: To evaluate the effect of postoperatively administering a low daily dose of tadalafil on the erectile function of patients who underwent a nerve-sparing radical prostatectomy(NSRP) due to localized prostate cancer (PCa). Materials and Methods: Of 138 patients, who underwent NSRP due to PCa between 2012 and 2014, 55 patients who had not had pre-operative erectile dysfunction (ED) were included in the study. The mean age of the patients was 64 (54-72). On the 15th day after surgery, after ultrasound evaluation, all 55 patients started on a daily dose of 5 mg tadalafil that was continued for 2.5 months. The erectile function of patients was evaluated pre-operatively, post-operatively, and at the 3rd and 6th month after surgery using the International Index of Erectile Function (IIEF-5) test. None of the patients was treated with hormonal therapy or radiotherapy before or after surgery. Results: Three patients were excluded from the study due to the adverse effects of tadalafil and two patients elected to discontinue the treatment. Of the remaining 50 patients whose pre-operative erectile function had been found normal, at 3 months after surgery, 36 (72%) had normal erectile function; of the remaining patients in the study six (12%) presented with mild, two (4%) with moderate, and six (12%) with severe ED. Six months after surgery, 35 patients (70%) had normal erectile function while seven (14%) had mild, three (6%) moderate and five (10%) severe ED. There was no statistically significant difference between the results obtained at the 3rd and 6thmonth follow-up (p > 0.05). Three patients reported adverse effects with tadalafil including flushes in 2 (3.6%) and a headache in 1 (1.8%). Conclusions: The administration of a 5 mg post-operative dose of tadalafil to patients that had undergone a bilateral NSRP was found to have a positive effect on the recovery and maintenance of erectile function. However, there is still a need to investigate a larger series of cases.

Keywords

Radical prostatectomy; Tadalafil; Erectile function

Full Text:

PDF
Submitted: 2015-07-28 15:14:18
Published: 2016-03-31 00:00:00
Search for citations in Google Scholar
Related articles: Google Scholar
Abstract views:
1577

Views:
PDF
830

Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM


Copyright (c) 2016 Erkan Hirik, Aliseydi Bozkurt, Mehmet Karabakan, Özkan Onuk, Mustafa Bahadır Can Balcı, Memduh Aydın, Murat Çakan, Barıs Nuhoglu

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
 
© PAGEPress 2008-2018     -     PAGEPress is a registered trademark property of PAGEPress srl, Italy.     -     VAT: IT02125780185